Who owns AgomAb Therapeutics NV ADR?
- CUSIP Number: 00860c102
Tip: Access positions for across all investors
Analyze quarterly positions in AgomAb Therapeutics NV with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of AgomAb Therapeutics NV stock
Who bought or sold AgomAb Therapeutics NV ADR this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Sanofi | 2.8M | $29M | 100% | Mar 2026 |
|
| Federated Investors | 1.6M | $17M | 100% | Mar 2026 |
|
| Andera Partners | 1.5M | $16M | 100% | Mar 2026 |
|
| Standard Life Aberdeen | 708k | $7.4M | 100% | Mar 2026 |
|
| Seven Grand Managers | 200k | $2.1M | 100% | Mar 2026 |
|
| Pfizer | 75k | $814k | 100% | Mar 2026 |
|
| Hrt Financial | 24k | $248k | 100% | Mar 2026 |
|
| Jane Street | 13k | $134k | 100% | Mar 2026 |
|
| UBS Group | 6.4k | $68k | 100% | Mar 2026 |
|
| SBI Securities | 2.00 | $21.000000 | 100% | Mar 2026 |
|